logo
Select company
Select metric
147.53%Free Cash Flow Margin
VS
Market
99
Sector
100
Industry
100
History
-
$ 9.84Close
$ 5.54 - $ 18.57 52-Week Range
Ticker Information

Ticker

KURA

Company Name

KURA ONCOLOGY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

KURA ONCOLOGY INC - Free Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

KURA - FCF % Historical data
DateFree Cash FlowFree Cash Flow MarginRevenues
6/30/2025$ 122.86M147.53%$ 83.28M
3/31/2025$ 110.55M162.6%$ 67.99M
12/31/2024$ 133.84M248.4%$ 53.88M
9/30/2024$ -169.24M0%$ 0
6/30/2024$ -154.84M0%$ 0
3/31/2024$ -138.01M0%$ 0
12/31/2023$ -124.99M0%$ 0
9/30/2023$ -117.21M0%$ 0
6/30/2023$ -109.55M0%$ 0
3/31/2023$ -114.37M0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • KURA ONCOLOGY INC's latest trailing twelve months (TTM) FCF % stands at 0%.
  • Over the past 5 years, KURA ONCOLOGY INC's average FCF % has been 186.18%.
  • The median FCF % for KURA ONCOLOGY INC during this period was 162.6%
  • KURA ONCOLOGY INC reached its highest FCF % over the past 5 years at 248.4%.
  • The lowest FCF % recorded by KURA ONCOLOGY INC in the same timeframe 147.53%

KURA ONCOLOGY INC's FCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

FCF % Benchmarks
CompanyFCF %
SAGE : SAGE THERAPEUTICS INC -410.94%NKTR : NEKTAR THERAPEUTICS -161.06%YMAB : Y-MABS THERAPEUTICS INC -20.99%TBPH : THERAVANCE BIOPHARMA INC 317.05%ADCT : ADC THERAPEUTICS SA -165.56%LXRX : LEXICON PHARMACEUTICALS INC -175.72%ZVRA : ZEVRA THERAPEUTICS INC -75.02%GYRE : GYRE THERAPEUTICS INC 0.07%GOSS : GOSSAMER BIO INC -383.67%TRDA : ENTRADA THERAPEUTICS INC -159.24%

Definition of Free Cash Flow Margin

[Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
FCF / Revenues
(=) FCF %
FCF % for KURA ONCOLOGY INC is calculated as follows: FCF [ $ -67.35M ] / Revenues [ $ 0 ]
(=) FCF % [ 0% ]

KURA - Free Cash Flow Margin, Last 5 years

147.53%

Minimum

Jun 30, 2025

248.4%

Maximum

Dec 31, 2024

186.18%

Average

162.6%

Median

FCF % Benchmark Analysis

The chart above depicts the distribution of FCF % for companies in the Total Stock Market. The average FCF % of the companies is 7.85% with a standard deviation of 19.48%.
The following table provides additional summary stats:
FCF % in the Market:
filtered constituents3.18K
min-58.23%
max68.19%
average7.85%
median7.37%
std19.48%